|
Market Closed -
London S.E.
11:35:25 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 144.00 GBX | -0.35% |
|
-5.88% | +12.50% |
| 07-29 | Diaceutics PLC Reports Revenue Results for the Half Year Ended 30 June 2026 | CI |
| 06-02 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 2.98x | - | 2.46x | 11.2x | 35.9x | -.--% | 166M | |
| -94.87x | 7.55x | 0.23x | 23.95x | 59.96x | -80.55x | -.--% | 69.91B | |
| -12.65x | - | -0.02x | 7.02x | 17.08x | 72.94x | - | 3.81B | |
| 32.91x | 3.48x | 0.47x | 2.45x | 21.13x | 35.84x | 1.44% | 3.6B | |
| 94.1x | 6.4x | 1.22x | 12.6x | 19.64x | 116.65x | 0.28% | 3.37B | |
| 34.9x | 12.69x | 2.17x | 10.97x | 23.69x | 27.57x | 1.96% | 2.01B | |
| 30.11x | 2.48x | 3.12x | 4.06x | 16.18x | 21x | 0.59% | 1.4B | |
| -79.85x | 3.99x | 0.94x | - | - | - | 0.09% | 1.36B | |
| 15.74x | 4.64x | 0.4x | - | - | - | 0.37% | 1.17B | |
| 37.17x | 7.74x | 1.04x | 15.33x | 23.87x | 26.13x | 0.63% | 1.13B | |
| -2.83x | - | 0.21x | 5.19x | 8.53x | 71.95x | -.--% | 716M | |
| -59.72x | 6.21x | 0.69x | 2.18x | 15.87x | -64.86x | - | 170M | |
| 24.52x | 3.1x | 1.45x | 2.62x | 8.28x | 13.78x | - | 160M | |
| Average | 1.63x | 5.57x | 0.99x | 8.08x | 20.49x | 25.12x | 0.54% | 6.84B | |
| Weighted average by Cap. | -69.68x | 7.26x | 0.38x | 20.85x | 52.16x | -53.99x | 0.14% |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
